BI
RDY icon

Binnacle Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Binnacle Investments’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$5.86K Sell
419
-165
-28% -$2.37K ﹤0.01% 504
2025
Q2 		$8.78K Hold
584
– – 0.01% 392
2025
Q1 		$7.7K Buy
+584
New +$8.06K 0.01% 371

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Binnacle Investments's RDY Position: Q3 2025 in Review

Binnacle Investments reduced its Dr. Reddy's Laboratories (RDY) stake by 28% in Q3 2025, selling an estimated $2.37K and leaving 419 shares worth $5.86K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Binnacle Investments first reported a position in RDY in Q1 2025 and has held it in 3 quarters since. The position peaked at $8.78K in Q2 2025. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

  • Binnacle Investments held 419 shares of Dr. Reddy's Laboratories worth $5.86K as of Q3 2025.
  • Binnacle Investments sold 165 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $2.37K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #504 holding.
  • Binnacle Investments first reported a position in Dr. Reddy's Laboratories in Q1 2025 and has held it in 3 quarters since.
  • Binnacle Investments's Dr. Reddy's Laboratories position peaked at $8.78K in Q2 2025.
  • 228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.